The standard test for lead poisoning in adults is a venous blood draw, where a small sample is taken from a vein in your arm and analyzed for lead concentration. Results are reported in micrograms per deciliter (µg/dL), and most labs can return results within a few days. This single test is the foundation for diagnosis, workplace screening, and treatment decisions.
The Venous Blood Lead Test
A venous blood sample is the gold standard. A healthcare provider draws blood from a vein, typically in your arm, and the sample is sent to a lab that measures whole-blood lead levels. The CDC recommends venous draws for confirmatory screening because they’re more reliable than fingerstick (capillary) samples, which can be contaminated by trace lead on the skin.
A capillary fingerstick can be used as a quick initial screen, but if that result comes back elevated, a venous draw is needed to confirm it. If your initial test was already a venous sample, you won’t need a second one.
No special preparation is required. You don’t need to fast, and the draw itself takes a few minutes. If you work in an industry with lead exposure, your employer may arrange testing on-site or through an occupational health clinic.
What the Numbers Mean
There is no “safe” blood lead level, but specific thresholds trigger different responses, particularly in workplace settings. For occupationally exposed adults, these are the key numbers:
- Below 5 µg/dL: Generally considered the goal. Even low levels can carry long-term health risks.
- 15 µg/dL: Some state agencies, like Michigan OSHA, require testing every two months once a worker reaches this level.
- 20 µg/dL: The American College of Occupational and Environmental Medicine recommends medical removal from lead exposure if a worker has two consecutive results between 20 and 29 µg/dL.
- 25 µg/dL: Federal OSHA considers this a serious finding that triggers an inspection.
- 30 µg/dL: Multiple occupational health organizations recommend removing the worker from lead exposure at this level.
- 50–60 µg/dL: Federal OSHA requires medical removal: 50 µg/dL for construction workers, 60 µg/dL for general industry workers.
For adults without occupational exposure, there are no universally mandated action levels, but most clinicians will investigate the source and discuss management at levels above 5 µg/dL.
When to Get Tested
Lead poisoning in adults often develops slowly, and symptoms can mimic many other conditions. Common signs include high blood pressure, joint and muscle pain, difficulty with memory or concentration, headaches, abdominal pain, and mood changes. In men, lead exposure can reduce sperm count and affect sperm quality. In women, it’s associated with miscarriage, stillbirth, and premature birth.
Because these symptoms are vague, testing often depends on recognizing your exposure risk rather than waiting for symptoms. Adults most likely to need screening include those who work in battery manufacturing or recycling, construction or demolition of older buildings, radiator repair, smelting, painting, plumbing, or firing ranges. Hobbies like stained glass work, pottery with lead glazes, and casting ammunition also carry risk. Living in a home built before 1978, especially during renovation, is another common source.
Occupational Screening Schedules
If you work with lead, federal OSHA mandates a specific testing schedule. Covered employees must have blood lead and zinc protoporphyrin levels checked at least every six months. If your result is at or above 40 µg/dL, that frequency increases to every two months until two consecutive results fall below 40. Workers who have been removed from lead exposure due to elevated levels must be tested monthly during the removal period.
Your employer is required to cover the cost of this monitoring and to share results with you. If your levels remain high, you’re entitled to medical removal with job protection and pay maintenance under the OSHA lead standards.
Urine Lead Testing
Urine tests can detect lead, but they are less accurate than blood tests. Research comparing the two biomarkers consistently shows blood lead has higher sensitivity and a stronger ability to discriminate between exposed and unexposed individuals. In one study of occupationally exposed workers, blood lead had an area under the curve (a measure of diagnostic accuracy) of 0.648 compared to 0.586 for urine. The gap widened further when participants were categorized by lead poisoning status.
Urine testing is sometimes used in research or environmental monitoring, but for clinical diagnosis, a blood test is the standard. You should not rely on a urine-only result to rule out lead exposure.
Zinc Protoporphyrin Testing
Zinc protoporphyrin (ZPP) is a substance that builds up in red blood cells when lead interferes with how your body makes hemoglobin. It can be measured alongside blood lead levels, and OSHA requires it as part of occupational monitoring. However, ZPP has significant limitations as a standalone diagnostic tool.
ZPP levels lag behind blood lead levels by 8 to 12 weeks, so it won’t catch a recent exposure. Its main clinical value is distinguishing between someone who was exposed recently and someone who has been overexposed for months. If your blood lead is elevated and your ZPP is also high, that points to chronic rather than acute exposure. ZPP can also be falsely elevated by iron-deficiency anemia, sickle cell anemia, and several other conditions unrelated to lead, which limits its specificity. It has no role in screening programs or in monitoring how well treatment is working.
Bone Lead Measurement
Blood lead reflects relatively recent exposure, with a half-life of about 30 days in adults. That means your blood level drops by half roughly every month after exposure stops. For someone concerned about years or decades of cumulative exposure, blood lead may underestimate the total body burden.
Bone lead measurement captures what blood tests miss. Lead stored in bone has a half-life of 20 to 30 years, making it a far better marker of lifetime exposure. The test uses a portable X-ray fluorescence device pointed at the shin bone (mid-tibia), which gives the most accurate estimate of long-term cumulative lead storage. The device sends low-energy X-rays into the bone and measures the characteristic energy that lead atoms release in response.
This test is primarily used in research settings and specialized occupational health clinics. It is not widely available in standard medical practice, and it requires correction factors to account for the thickness of skin and tissue over the bone. Still, studies have found that bone lead measurements often show stronger associations with health outcomes than blood levels alone, particularly for conditions like chronic kidney disease and cognitive decline that develop over many years of exposure.
Tests That Are No Longer Recommended
You may encounter references to a “chelation challenge test” or “provocation test,” where a chelating agent is given to pull lead out of tissues, and then urine is collected to measure how much lead was mobilized. This test is no longer recommended by any major medical authority. The American College of Medical Toxicology, the CDC, and the Agency for Toxic Substances and Disease Registry have all published statements against it. The test is expensive, difficult to interpret, and can actually worsen lead toxicity by redistributing lead from bones into the bloodstream and organs. If a provider suggests this approach, it is outdated practice.